A detailed history of Glen Eagle Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 91 shares of OGN stock, worth $1,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Holding current value
$1,862
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $1,954 - $2,459
-112 Reduced 55.17%
91 $1.88 Million
Q1 2024

Jul 03, 2024

BUY
$13.78 - $18.8 $2,797 - $3,816
203 New
203 $3.82 Million
Q4 2023

Aug 13, 2024

SELL
$10.95 - $17.32 $339 - $536
-31 Reduced 13.54%
198 $2.86 Million
Q3 2023

Aug 13, 2024

SELL
$16.59 - $23.77 $99 - $142
-6 Reduced 2.55%
229 $3.98 Million
Q2 2023

Aug 13, 2024

BUY
$19.27 - $24.63 $366 - $467
19 Added 8.8%
235 $4.89 Million
Q1 2023

Aug 13, 2024

SELL
$21.42 - $32.08 $299 - $449
-14 Reduced 6.09%
216 $5.08 Million
Q4 2022

Aug 13, 2024

SELL
$23.31 - $28.61 $5,734 - $7,038
-246 Reduced 51.68%
230 $6.42 Million
Q3 2022

Aug 13, 2024

SELL
$23.4 - $34.25 $1,216 - $1,781
-52 Reduced 9.85%
476 $11.1 Million
Q2 2022

Aug 13, 2024

BUY
$31.66 - $38.9 $664 - $816
21 Added 4.14%
528 $17.8 Million
Q1 2022

Aug 13, 2024

SELL
$30.45 - $39.36 $1,552 - $2,007
-51 Reduced 9.14%
507 $17.7 Million
Q4 2021

Aug 13, 2024

SELL
$28.67 - $37.13 $5,389 - $6,980
-188 Reduced 25.2%
558 $17 Million
Q3 2021

Aug 13, 2024

SELL
$28.63 - $35.64 $343 - $427
-12 Reduced 1.58%
746 $24.1 Million
Q2 2021

Aug 13, 2024

BUY
$28.45 - $38.0 $15,789 - $21,090
555 Added 273.4%
758 $22.9 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.21B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.